whodathunkit
Senior Member
- Messages
- 1,160
I'm reposting this since this thread got merged with another one started earlier, I think from another forum. I didn't see the original thread.
Also, dunno if anyone else remembers this, but some years ago (over a decade but don't know exactly how long, maybe as long as 20 years), Solgar got bought out by a big pharmaceutical company. I remember when this happened because I am an avid label reader, and Solgar used to be a very good (if pricey) brand with a reputation for using quality ingredients. Then suddenly "dicalcium phosphate" and all kinds of crap started popping up in their ingredients list. I quit buying them. Then one day I was moaning to a worker in a health food store about the inexplicable loss of Solgar quality, and that's when I learned that Solgar had been bought out. Didn't know by who, however.
Then a few months ago I was talking to someone in a store about Solgar again, and they said it was Merck that had originally bought them out. They also said Solgar was "okay to buy" again because Merck had recently sold the company back to the original owner and the quality was back. They said Merck sold Solgar back because it started losing money after Merck took it over. Way to go, geniuses, start putting crap into formerly good quality products and of course sales will go down!
Anyway, now I'm wondering if this has anything to do with that. Like, since Merck is no longer into supplements they're trying to get their ingredients pulled.
Anybody know anything about this?
whodathunkit said:I'm not sure how Merck could make *more* money off of metafolin by putting up gatekeepers (i.e., pharmacies and doctors) between consumers and folate supplements. It's more likely they'd *lose* a bunch of money, if for no other reason than most doctors don't understand when or how to prescribe folate. Sales volume of metafolin would likely go so far down that they wouldn't be able to make up the profit even with an insane price hike on the prescription form. So *if* Merck is smart (big "if", I know), they'll help keep metafolin on the free market where the real money is to be made.
But if it's about control by agencies other than the actual ingredients manufacturers, the profit motive doesn't even enter into it.
Also, dunno if anyone else remembers this, but some years ago (over a decade but don't know exactly how long, maybe as long as 20 years), Solgar got bought out by a big pharmaceutical company. I remember when this happened because I am an avid label reader, and Solgar used to be a very good (if pricey) brand with a reputation for using quality ingredients. Then suddenly "dicalcium phosphate" and all kinds of crap started popping up in their ingredients list. I quit buying them. Then one day I was moaning to a worker in a health food store about the inexplicable loss of Solgar quality, and that's when I learned that Solgar had been bought out. Didn't know by who, however.
Then a few months ago I was talking to someone in a store about Solgar again, and they said it was Merck that had originally bought them out. They also said Solgar was "okay to buy" again because Merck had recently sold the company back to the original owner and the quality was back. They said Merck sold Solgar back because it started losing money after Merck took it over. Way to go, geniuses, start putting crap into formerly good quality products and of course sales will go down!
Anyway, now I'm wondering if this has anything to do with that. Like, since Merck is no longer into supplements they're trying to get their ingredients pulled.
Anybody know anything about this?